Lindbrook Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1
Closed -$1 2869
2023
Q2
$1 Hold
1
﹤0.01% 2703
2023
Q1
$1 Hold
1
﹤0.01% 2769
2022
Q4
$0 Hold
1
﹤0.01% 3057
2022
Q3
$0 Hold
1
﹤0.01% 2995
2022
Q2
$0 Hold
1
﹤0.01% 2858
2022
Q1
$0 Buy
+1
New +$1 ﹤0.01% 2658
2021
Q3
Sell
-625
Closed -$2K 2040
2021
Q2
$2K Buy
625
+285
+84% +$990 ﹤0.01% 1677
2021
Q1
$1K Sell
340
-448
-57% -$1.61K ﹤0.01% 1834
2020
Q4
$3K Hold
788
﹤0.01% 1395
2020
Q3
$3K Buy
788
+448
+132% +$1.7K ﹤0.01% 1331
2020
Q2
$1K Buy
+340
New +$991 ﹤0.01% 1667

Lindbrook Capital's SPPI Position: Q3 2023 in Review

Lindbrook Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 1 share — an estimated $1 sold.

Lindbrook Capital first reported a position in SPPI in Q2 2020 and held it in 11 quarters. The position peaked at $3K in Q4 2020. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Lindbrook Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Lindbrook Capital sold 1 Spectrum Pharmaceuticals Inc share in Q3 2023, an estimated $1.
  • Lindbrook Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2020 and held it in 11 quarters.
  • Lindbrook Capital's Spectrum Pharmaceuticals Inc position peaked at $3K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.